The goal of Vaccine Technology IV is to gather together many of the key leaders in the field to discuss and review progress made in generating new vaccine targets, new technologies for vaccines and new adjuvants.
Key strategic issues will also be discussed, such as how to generate a new vaccine very quickly, and also how to make vaccines more available to the developing world.
Nicolas Havelange will give a presentation entitled Challenges in clinical batches production of malaria vaccines.